Author

Veronica C. Galvin

Duke UniversityORCID 0000-0003-2198-4320Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:non-human primate· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:electronic health records· 1 Approach:experimental assay· 1 Research Focus:spatial domain detection· 1 Approach:statistical model· 1

Frequent Co-Authors

Amy F.T. ArnsteniD· 1 shared Anita A. DisneyiD· 1 shared Athena May· 1 shared David A. LewisiD· 1 shared Dibyadeep DattaiD· 1 shared Elizabeth WooiD· 1 shared Emi LingiD· 1 shared Fenna M. KrieneniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Amy F.T. ArnstenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintJul 14, 2026

Nicotine causes highly localized and tuned changes in thalamocortical gain that cascade strongly and selectively through the cortical circuit

Veronica C. Galvin, Anita A. Disney

The paper shows nicotine alters thalamocortical gain in a localized, tuned manner, affecting cortical activity and perceptual performance through normalization mechanisms.

DOI 10.64898/2026.02.22.707315

non-human primateelectronic health records

𝕏 PostBluesky

NeurosciencebioRxivPreprintJun 13, 2024

Kynurenic acid inflammatory signaling expands in primates and impairs prefrontal cortical cognition

Shengtao Yang, Dibyadeep Datta, Fenna M. Krienen…·Min Wang

This study shows that kynurenic acid (KYNA) and its enzyme KAT II expand in primate dlPFC, impairing cognitive functions by affecting NMDA and nic-7Rs, and suggests targeting KYNA as a therapeutic approach for neuroinflammatory disorders.

4 citations

non-human primateexperimental assay

𝕏 PostBluesky